logo
episode-header-image
Jun 2024
14m 59s

ASCO2024 special: Circulating kidney inj...

EUROPEAN ASSOCIATION OF UROLOGY
About this episode
In this podcast, UROONCO RCC chief editor Dr. Maria Carmen Mir (ES) talks to Prof. Laurence Albiges (FR) on the abstract she recently presented at ASCO2024 - “Circulating kidney injury molecule-1 (KIM-1) biomarker analysis in IMmotion010: A randomised phase 3 study of adjuvant (adj) atezolizumab (atezo) vs placebo (pbo) in patients with renal cell carcinoma ... Show More
Up next
Yesterday
TALAPRO-3 in mCSPC: Prof. Agarwal discusses the trial results
In this episode, UROONCO PCa associate editor Prof. Claudia Kesch interviews Dr. Neeraj Agarwal, from Dana-Farber Cancer Institute on the recent results of the TALAPRO-3 trial. This trial investigates the efficacy and safety of TALA + ENZA in men with mCSPC bearing HRR gene alter ... Show More
19m 30s
Oct 3
EAU Section of Urological Imaging: Small renal masses beyond surgery: Imaging, biopsy, active surveillance and ablative technologies
How can small renal masses be managed beyond surgery, and how should the most appropriate approach be selected for each patient?In this episode, Prof. Daniela Oprea-Lager (NL) is joined by Assoc. Prof. Lorenzo Bianchi (IT) and Dr. Giuseppe Basile (GB) to discuss the evolving mana ... Show More
24m 2s
Sep 26
Dr. Béatrice Bouchard discuss membranous urethral length and post-prostatectomy stress urinary incontinence
In “Membranous urethral length and post-prostatectomy stress urinary incontinence”, Dr. Béatrice Bouchard (CA) examines membranous urethral length (MUL) as a predictor of continence outcomes after prostatectomy. Based on a retrospective study of 161 men, she shows that patients w ... Show More
6m 26s
Recommended Episodes
Jun 2024
GU Oncology Highlights From ASCO24
tail spinning
34m 54s
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
57m 23s
Oct 2021
Oncology | Renal Cell Carcinoma
In this episode, we review the high-yield topic of Renal Cell Carcinoma from the Oncology section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets 
12m 40s
Oct 2021
Renal Cell Carcinoma
<p>This episode covers renal cell carcinoma.<br/><br/>Written notes can be found at <a href='https://zerotofinals.com/surgery/urology/renalcellcarcinoma/'>https://zerotofinals.com/surgery/urology/renalcellcarcinoma/</a> or in the urology section of the Zero to Finals surgery book ... Show More
6m 31s
Jun 2022
Ep 6: Inflammatory Biomarkers and Cardiovascular Risk
What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event? Join Dr Bruna Gigante (Karolinska Institute, Solna, SE) in a discussion of potential biomarkers which may impact a patient’s cardiovascular risk profile. In this month’s feat ... Show More
28m 46s
Jul 2023
Episode 14: CKD Evaluation & Measurement
In this episode, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Dr. Magdalena Madero (National Heart Institute Mexico City, Mexico) discuss best practices for CKD evaluation and measurement. This episode focuses on the importance of assessing GFR and albuminuria, iden ... Show More
16 m
Jul 2023
Episode 16: Appropriate CKD Referral to Specialists
In this episode, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Ikechi Okpechi (University of Alberta, Canada) discuss the right time to refer patients with CKD to a nephrologist. This episode also addresses rapid CKD progression and the utility of risk prediction equ ... Show More
16 m
May 2024
Key Abstracts in GU Cancers at ASCO24
tail spinning
26m 4s
Mar 2024
Episode 171: ASCO-GU Top Clinical Data With Pedro Barata
Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he de ... Show More
46m 7s